it is concluded that the risk of paradoxical bronchoconstriction with ipratropium bromide is considerably reduced by removal of benzalkonium chloride and edta and that preservative free ipratropium bromide is a more potent bronchodilator than the currently available atrovent solution .
C0700580
ipratropium bromide
C0591130
atrovent